Harmony Biosciences (HRMY)
36.13
+0.10 (0.28%)
Upcoming Events
Latest Headlines
Mizuhoon Harmony Biosciences (HRMY): 'we recommend being opportunistic on yesterday's share weakness'
October 23, 2026 7:11 AM - StreetInsider
Harmony Biosciences to Report Third Quarter 2026 Financial Results on November 4, 2026
October 20, 2026 8:05 AM - StreetInsider
Ladenburg Thalmann Starts Harmony Biosciences Holdings Inc. (HRMY) at Buy
October 15, 2026 7:17 AM - StreetInsider
Form 8-K Harmony Biosciences Hold For: Oct 12
October 13, 2026 8:00 AM - SEC Filing
H.C. Wainwright Reiterates Buy Rating on Harmony Biosciences Holdings Inc. (HRMY)
October 13, 2026 6:49 AM - StreetInsider
Truist Securitas's Biotechnology Earnings Preview: 'INSM, BBIO, NBIX Most Levered to the Print'
October 12, 2026 9:04 AM - StreetInsider
Harmony Biosciences names new CEO effective January 2027
October 12, 2026 7:00 AM - StreetInsider
Harmony Biosciences Announces Planned CEO Transition to Support Next Phase of Growth
October 12, 2026 7:00 AM - StreetInsider
Harmony Biosciences Announces Poster Presentation at the 17th European Narcolepsy Days
October 1, 2026 8:05 AM - StreetInsider
Oppenheimer Reiterates Outperform Rating on Harmony Biosciences Holdings Inc. (HRMY)
September 24, 2026 5:42 AM - StreetInsider
Form 4 Harmony Biosciences Hold For: Sep 16 Filed by: Budur Kumar
September 18, 2026 4:48 PM - SEC Filing
Form 144 Harmony Biosciences Hold Filed by: Budur Kumar
September 18, 2026 4:20 PM - SEC Filing
Form 144 Harmony Biosciences Hold Filed by: Budur Kumar
September 17, 2026 4:35 PM - SEC Filing
Form 144 Harmony Biosciences Hold Filed by: Budur Kumar
September 16, 2026 4:34 PM - SEC Filing
Harmony Biosciences Announces Poster Presentations at the 16th European Epilepsy Congress
September 3, 2026 8:05 AM - StreetInsider
Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference
August 27, 2026 8:05 AM - StreetInsider
Wolfe Research Starts Harmony Biosciences Holdings Inc. (HRMY) at Outperform
August 26, 2026 5:32 AM - StreetInsider
Form 144 Harmony Biosciences Hold Filed by: Valor IV Pharma Holdings, LLC
August 7, 2026 4:48 PM - SEC Filing
Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium
August 6, 2026 8:05 AM - StreetInsider
Harmony Biosciences Holdings Inc. (HRMY) PT Lowered to $70 at Oppenheimer
August 4, 2026 2:30 PM - StreetInsider
Form 10-Q Harmony Biosciences Hold For: Jun 30
August 4, 2026 8:17 AM - SEC Filing
Form 8-K Harmony Biosciences Hold For: Aug 04
August 4, 2026 8:05 AM - SEC Filing
Harmony Biosciences Announces Record Q2 2026 Revenue and Shares Initial Clinical Data for Its Orexin-2 Agonist BP-205 Reinforcing Potential Best-in-Class Profile
August 4, 2026 7:30 AM - StreetInsider
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $51 at Mizuho
August 3, 2026 6:36 AM - StreetInsider
Form SCHEDULE 13G Harmony Biosciences Hold Filed by: VANGUARD PORTFOLIO MANAGEMENT LLC
July 31, 2026 11:24 AM - SEC Filing
Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $51 at Mizuho
July 31, 2026 6:53 AM - StreetInsider
Form SCHEDULE 13G/A Harmony Biosciences Hold Filed by: BlackRock, Inc.
July 28, 2026 4:47 PM - SEC Filing
Full Article List
